For example, DNA demethylating agents and HDAC inhibitors have been shown to upregulate MHC class I expression, antigen processing machinery, and interferon-stimulated genes in pediatric brain tumor models, including glioma and medulloblastoma [26,90]. The gene discussed is HDAC9; the disease is central nervous system cancer.